Equities

Chemed Corp

Chemed Corp

Actions
Health CareHealth Care Providers
  • Price (USD)585.27
  • Today's Change7.61 / 1.32%
  • Shares traded69.27k
  • 1 Year change+14.24%
  • Beta0.4440
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2647433
Total Receivables, Net182139137
Total Inventory121010
Prepaid expenses434950
Other current assets, total------
Total current assets501273230
Property, plant & equipment, net330335319
Goodwill, net585581579
Intangibles, net90100108
Long term investments1069399
Note receivable - long term1.661.83--
Other long term assets53568.14
Total assets1,6681,4421,343
LIABILITIES
Accounts payable484261
Accrued expenses196189190
Notes payable/short-term debt16012
Current portion long-term debt/capital leases05.00--
Other current liabilities, total526139
Total current liabilities312297302
Total long term debt093185
Total debt1698197
Deferred income tax303923
Minority interest------
Other liabilities, total218215209
Total liabilities560643719
SHAREHOLDERS EQUITY
Common stock373737
Additional paid-in capital1,3411,1501,044
Retained earnings (accumulated deficit)2,4472,1981,970
Treasury stock - common(2720)(2588)(2430)
Unrealized gain (loss)------
Other equity, total2.082.252.20
Total equity1,108799623
Total liabilities & shareholders' equity1,6681,4421,343
Total common shares outstanding151515
Treasury shares - common primary issue222222
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.